Amneal Acquires Saol Therapeutics’ Baclofen Franchise
January 05, 2022 – Expands Amneal’s Neurology Presence into Spasticity BRIDGEWATER, N.J. & ROSWELL, Ga.–(BUSINESS WIRE)– Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal”) and Saol Therapeutics,